All research papers

Towards effective and efficient patient-specific quality assurance for spot scanning proton therapy.

A deformable head and neck phantom with in-vivo dosimetry for adaptive radiotherapy quality assurance.

Eye lens dose in interventional cardiology.

Evaluation of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy.

Occupational radiation dose to eyes from interventional radiology procedures in light of the new eye lens dose limit from the International Commission on Radiological Protection.

A review of recent advances in optical fibre sensors for in vivo dosimetry during radiotherapy.

Initial clinical experience with a radiation oncology dedicated open 1.0T MR-simulation.

Percent depth-dose distribution discrepancies from very small volume ion chambers.

Intensity-modulated Total Body Irradiation (TBI) with TomoDirect™.

Towards adaptive IMRT sequencing for the MR-linac.

Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment.

Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging.

Occupational health hazards of working in the interventional laboratory: a multisite case control study of physicians and allied staff.

Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis.

Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation.

Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue.

Dose response of pancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE.

Dosimetric effects of immobilization devices on SABR for lung cancer using VMAT technique.

Correcting lateral response artifacts from flatbed scanners for radiochromic film dosimetry.

The first clinical treatment with kilovoltage intrafraction monitoring (KIM): a real-time image guidance method.

Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.

Influence of dosemeter position for the assessment of eye lens dose during interventional cardiology.

Heart dose reduction by prone deep inspiration breath hold in left-sided breast irradiation.

Internal dosimetry of nuclear medicine workers through the analysis of (131)I in aerosols.

The UK HeartSpare Study (Stage IB): randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgery.

A Survey of Stereotactic Body Radiotherapy in Korea.

The use of dual vacuum stabilization device to reduce kidney motion for stereotactic radiotherapy planning.

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.

Modulation indices for volumetric modulated arc therapy.

Correlation of phantom-based and log file patient-specific QA with complexity scores for VMAT.

Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial.

Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis.

IMRT, RapidArc® and conformal radiotherapy in the treatment of tumours of the anal canal.

Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors.

A comparison between four immobilization systems for pelvic radiation therapy using CBCT and paired kilovoltage portals based image-guided radiotherapy.

IMRT and RapidArc commissioning of a TrueBeam linear accelerator using TG-119 protocol cases.

Characterization of MOSkin detector for in vivo skin dose measurement during megavoltage radiotherapy.

Hybrid micro-particles as a magnetically-guidable decontaminant for cesium-eluted ash slurry.

Monte Carlo modeling provides accurate calibration factors for radionuclide activity meters.

The value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature.

Fundamental study of a real-time occupational dosimetry system for interventional radiology staff.

²¹³Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience.

(44)Sc: an attractive isotope for peptide-based PET imaging.

Prospective phase II trial of image-guided radiotherapy in Hodgkin lymphoma: benefit of deep inspiration breath-hold.

Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT.

Assessing the deviation from the inverse square law for orthovoltage beams with closed-ended applicators.

Intra- and intervariability in beam data commissioning among water phantom scanning systems.

Comparison of somatostatin receptor agonist and antagonist for peptide receptor radionuclide therapy: a pilot study.

An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer.

Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.

A proton beam therapy system dedicated to spot-scanning increases accuracy with moving tumors by real-time imaging and gating and reduces equipment size.

Surgeons' exposure to radiation in single- and multi-level minimally invasive transforaminal lumbar interbody fusion; a prospective study.

Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study.

Toward adaptive radiotherapy for head and neck patients: Feasibility study on using CT-to-CBCT deformable registration for "dose of the day" calculations.

Dose error from deviation of dwell time and source position for high dose-rate 192Ir in remote afterloading system.

DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapy.

Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours.

Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance.

The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?

Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate.